Metformin Monotherapy vs Predominantly Older Non-Metformin Antidiabetic Medications for Cerebrovascular Risk in Early Type 2 Diabetes Management
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Metformin monotherapy versus predominantly older non-metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management
Diabetes Obes Metab 2024 Jul 02;[EPub Ahead of Print], M Sun, Z Lu, WM Chen, S Lv, N Fu, Y Yang, Y Wang, M Miao, SY Wu, J ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.